Free tool
Stocks far below their 52-week high
We cover 9 companies trading at least 50% below their own 52-week high. The median market value in the group is $9.94B. Across the group, the median move over the past trading day is −0.45%. Price change over the past year runs from −61.8% to −40.5% across the middle 80 percent of the group, with a median of −49.5%.
Other lists in this group
Table
9 of 4,095 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| BSX | Boston Scientific Corporation | $69.81B | Large cap | −54.50% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $32.12B | Large cap | −47.38% |
| ZTS | Zoetis Inc. | $32.03B | Large cap | −49.50% |
| SMMT | Summit Therapeutics Inc. | $11.35B | Large cap | −42.63% |
| PODD | Insulet Corporation | $9.94B | Mid cap | −57.12% |
| HIMS | Hims & Hers Health, Inc. | $6.96B | Mid cap | −32.22% |
| DOCS | Doximity, Inc. | $4.41B | Mid cap | −63.61% |
| RGC | Regencell Bioscience Holdings Limited | $2.72B | Mid cap | −61.38% |
| ADMA | ADMA Biologics, Inc. | $2.16B | Mid cap | −44.17% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.